Skip to content

Schrodinger SDGR Price / sales

Price / sales at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
13.9×-0.4×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
24.4×-11.1×
Absci Corporation logo
Absci CorporationABSI
250×+184×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
13.4×-15.4×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
166.6×+109×
Certara, Inc. logo
Certara, Inc.CERT
2.2×-1.9×

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-23.7%
Enterprise value$984.71M-23.1%

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Calculated from Schrodinger’s reported figures.

Based on the most recent quarter.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's price / sales?
Schrodinger (SDGR) reported price / sales of 3.3× in Q1 2026.
How has Schrodinger's price / sales changed year-over-year?
Schrodinger's price / sales decreased by 47.4% year-over-year, from 6.3× to 3.3×.
What is the long-term trend for Schrodinger's price / sales?
Over 5 years (2020 to 2025), Schrodinger's price / sales has grown at a -36.9% compound annual growth rate (CAGR), from 51.3× to 5.1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.